International Journal of Impotence Research Aug 29, 2008
Celebrating its 20th anniversary, IJIR continues to publish the most essential research on male and female sexual dysfunction, including important information related to cardiovascular disease, diabetes, menopause and vascular deficits ... Visit the to take advantage of this opportunity and to read high-impact research on male and female sexual dysfunction for only an additional $75 per year ... Female Sexual Dysfunction Online is an educational source for clinicians and researchers to obtain... (Nature News Service)
Study: Viagra Could Improve Womens Sexual Satisfaction As Well Jul 26, 2008
The study was funded by Pfizer whose spokesperson, Sally Beatty said the company has no plans to pursue FDA approval for using Viagra as a treatment for female sexual dysfunction. Viagra sales totaled $1. (eFluxMedia)
Sildenafil Reduces Adverse Effects Jul 25, 2008
Sildenafil had been tested on women in the past and had not been found to be effective in improving female sexual dysfunction in the general population. It is unknown why it may have worked more successfully in this sub-group. (Suite101.com)
Women on antidepressants may benefit from Viagra Jul 24, 2008
Pfizer Inc. spokeswoman Sally Beatty said the company currently has no plans to pursue FDA approval for using its drug Viagra as a treatment for female sexual dysfunction. The company ended its internal research on Viagra for women in 2004. (The Delaware County Times, PA)
Surgeon Attacks Female Sexual Dysfunction Jul 4, 2008
Destigmatizing Female Sexual Dysfunction ... Many women remain untreated because of the taboos associated with female sexual dysfunction, a term that relates to problems that affect a woman's sex life, including inability to achieve orgasm, decreased sex drive, arousal disorder, vaginal dryness and sexual pain disorders ... Dr. Karen Boyle, a urologist at Johns Hopkins Hospital who specializes in both male and female sexual dysfunction, said that many women have misconceptions about their sexual... (ABC News)
Palatin layoffs continue May 14, 2008
Palatin's bremelanotide, a nasal spray that works through the central nervous system, had shown promise in early clinical trials as a treatment for both male and female sexual dysfunction. That promise eroded last summer, after federal regulators raised questions about spikes in blood pressure from the drug. (NJ.com -- Times)
Science tackles female sexual dysfunction Apr 1, 2008
Most medical schools don't address women's sexual health, and female sexual dysfunctions often are complicated, caused by a varied mix of physical and psychological issues. There aren't many mainstream, easily accessible treatments available and there are no drugs in the United States for treating women's sexual dysfunctions, although there are off-label treatments doctors can use, including hormones and topical anesthetics to dull pain. (San Francisco Chronicle)
Decreased sexual satisfaction is not associated with cardiovascular disease in postmenopausal women Mar 29, 2008
Female sexual dysfunction is a common condition and has been linked to a higher burden of medical illnesses that can cause cardiovascular disease. In men, erectile dysfunction is clearly linked to the development of cardiovascular disease. (EurekAlert!)
Health: Happy birthday, pop culture icon Viagra Mar 28, 2008
In some camps, there's even disagreement about what constitutes female sexual dysfunction. With so many older women reporting little desire, some psychologists object to the medicalization of what might be a normal phase of a female's life or a reasonable response to conditions in a marriage. (San Diego Union-Tribune)
New Line's got 'Chemistry' Dec 6, 2007
"Chemistry for Beginners" is the story of a shy university biochemist running a research project into female sexual dysfunction. With the big drug companies clamoring for results, he becomes caught in a triangle of intrigue and attraction between his female co-researcher and a pretty student who shows an unexpected response to his experimental treatment. (Variety)
Noble Financial TWO DOUBLE-O-SEVEN Equity Conference Presenter Profiles Aug 18, 2007
BioSante's lead products include Elestrin(TM) (estradiol gel) developed through FDA approval by BioSante indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, marketed in the U.S. by Bradley Pharmaceuticals, Inc., BioSante's licensee, and LibiGel(R) (transdermal testosterone gel) in Phase III development by BioSante for the treatment of female sexual dysfunction (FSD). Also in development is Bio-T-Gel(TM), a testosterone gel for male hypogonadism, and an... (Yahoo! Wire -- Entertainment News)
Diabetes menace'Problems with sex nearly drove us to divorce' Aug 8, 2007
The site is designed to provide a wide range of information on diabetes and sexual health, focusing on ED and female sexual dysfunction (FSD) and illustrates them with 'true life stories. It looks at what could be the causes and how to treat them as well as where to go to get help. (BBC News -- Health)
A step closer to his dream Aug 4, 2007
It's been about two years since the 57-year-old urologist left Boston University, where he spent three decades pioneering research on impotency and female sexual dysfunction ... Female sexual dysfunction is a concocted term, said Dr. Leonore Tiefer, an associate professor of psychiatry at the New York University School of Medicine. (San Diego Union-Tribune -- Business)
Sexual Dysfunction Study Designed To Help Women May 9, 2007
HSDD is the most common form of female sexual dysfunction, characterized by decreased sexual thoughts and feelings as well as a loss of desire for sex ... There is a school of thought that perhaps physiologic changes in the female brain may be associated with female sexual dysfunction. (Science Daily)
Top Ways To Save Your Sex Drive May 4, 2007
If so, you may have female sexual dysfunction and you're not alone. An estimated 43 percent of women reported experiencing sexual dysfunction, according to findings published in the Journal of the American Medical Association, with problems ranging from not being able to have orgasms to having zero sexual desire. (CBS New York, NY)
Midlife can put women's hormones in neutral Apr 14, 2007
Studies to assess its risks are now under way, but in the meantime testosterone is not approved to treat female sexual dysfunction in this country. But women still ask for it. (Herald Online, SC -- Health)
We've got the pills, so you must have a problem Apr 3, 2007
The drug companies, meanwhile, overplay the role of medication in the treatment of mild depression, and sell new conditions like "restless legs syndrome", or "female sexual dysfunction", for treatment with pills which they, too, already had in the warehouse. Pills are seductive and easy, especially for problems with a strong psychological or social component; but the tragedy is, in the UK, there is nobody advocating against this disempowering pill mentality: only different groups, some of whom... (Guardian Unlimited -- Life)
Novavax full-year loss doubles Mar 14, 2007
It also continues to work with the on a vaccine candidate for the virus that causes AIDS, and on a testosterone-based product for the treatment of female sexual dysfunction. Novavax (NASDAQ: NVAX) ended the year with $73. (Baltimore Business Journal, MD)
His and hers Viagra Mar 11, 2007
Pfizer set up a female sexual dysfunction unit a few years ago, comparing Viagra in women to a placebo, but the study had to be stopped because 85 per cent of the women responded to the placebo. It seems that even the very idea of Viagra is enough to make some women aroused. (Guardian Unlimited)
How To Spice Up Your Sex Life Feb 12, 2007
Procter e (nyse: - - ) tried to push a testosterone patch for female sexual dysfunction through the Food and Drug Administration (FDA) but in 2004 the agency balked, citing a lack of long-term safety data ... Right now, the treatment available for women with female sexual dysfunction that has been reviewed by the FDA is a handheld vacuum that can be used with a doctor's prescription to increase blood flow to the clitoris. (Forbes)
Pursuit of better sex through science Feb 10, 2007
Procter & Gamble tried to push a testosterone patch for female sexual dysfunction through the Food and Drug Administration (FDA), but in 2004 the agency balked, citing a lack of long-term safety data ... What really worksRight now, the treatment available for women with female sexual dysfunction that has been reviewed by the FDA is a handheld vacuum that can be used with a doctor's prescription to increase blood flow to the clitoris. (MSNBC -- Health)
Abnormal Pap Smears Not Unusual Dec 22, 2006
A report, published in health journal Sexual Health, has found nearly all women had had at least one Pap smear test in their lives with 26 percent reporting an abnormal result. Two thirds of these women were treated at clinics after abnormal tests with about one in five women reporting negative effects on their sex lives. (Science Daily)
Women Match Men In Sexual Arousal Time Oct 4, 2006
Study: There May Finally Be Drug That Treats Female Sexual Dysfunction. Drug's Success Touches Off Search For Female Sex Drug. (CBS News)
Palatin Technologies to Present at ThinkEquity Partners 4th Annual ... Sep 7, 2006
The Company's lead product candidate, bremelanotide, is currently in Phase II clinical trials for both male and female sexual dysfunction. The Company's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. (Genetic Engineering News (press release), NY)
Future of sex Aug 18, 2006
Earlier this month, Palatin Technologies announced that a trial of its new drug for post-menopausal female sexual dysfunction succeeded in rejuvenating desire in women who had little of it. The drug, a so-called melanocortin agonist, acts through the central nervous system. (MSNBC -- Health)
Blood Pressure and Women's Sex Drive May 21, 2006
Since female sexual dysfunction greatly affects patients and their sexual partners quality of life, it seems of great importance to properly recognize and manage female sexual dysfunction in hypertensive women ... Exactly how high blood pressure and female sexual dysfunction are connected is not clear, he says ... Women are more complex than men and many things affect their sexual desire and arousal, he says, We do know that you need a decent blood supply to the clitoris and vagina to have an... (WebMD)
What hampers a woman's sexual desire? May 21, 2006
They found that female sexual dysfunction (FSD) is more prevalent in women with hypertension, the medical term for high blood pressure, compared to those with normal blood pressure. The researchers who presented their study recently at the 21st Annual Meeting of the American Society of Hypertension in New York City also said that the age and duration of hypertension appear to be significant predictors of FSD, according to Newswise wire. (Hindustan Times)
Weight-Loss Gainers May 13, 2006
a treatment for female sexual dysfunction, is in a Phase II trial. And a testosterone spray to counter a lack of desire in women will soon enter a Phase II trial. (SmartMoney)
Older Women Report Satisfying Sex Lives Apr 28, 2006
I offer my opinion that the definition of female sexual dysfunction is such a problem because female sexual dysfunction does not exist as a diagnosis, Gierhart writes. I believe that it is a spectrum of disorders with extensive overlap between the disorders. (Fox News)
Study: Women over 40 still enjoying sex Apr 27, 2006
The reader is advised to approach all female sexual dysfunction prevalence studies with caution until researchers accept a standard definition, she writes. Copyright 2006 Reuters Limited. (MSNBC -- Health)
Global survey tracks older pairs' sex lives Apr 24, 2006
Statistics about female sexual dysfunction surprisingly were similar. "Anywhere you go in the world, one woman in three reports sexual problems that are affecting her happiness. . . . Without population studies, we'd never even know there's a problem," Laumann said. (AZCentral -- News)
SEX IN A SPRAY... Apr 23, 2006
Approval as a treatment for female sexual dysfunction may follow. In the wake of Pfizer's failed attempts to prove Viagra works for women and amid growing recognition that it also doesn't work for large numbers of men, these two markets alone could make PT-141 a pharmaceutical blockbuster. (The Drudge Report)
[extra: Longer version] Apr 19, 2006
Among the diseases highlighted in PloS Medicine as subjects of disease mongering campaigns are male and female sexual dysfunction, attention deficit hyperactivity disorder, bipolar disorder, and restless legs syndrome. In one of the articles Steven Woloshin and Lisa Schwartz of Dartmouth Medical School in New Hampshire reviewed newspaper coverage of restless legs syndrome, which began to attract media attention in the United States soon after GlaxoSmithKline launched an awareness campaign in... (British Medical Journal)
A case of disease by design Apr 19, 2006
The latter, according to some of the world's biggest, most profitable pharmaceutical companies, which have come up with a range of new drugs to treat "restless legs syndrome", attention deficit hyperactivity disorder in children, and female sexual dysfunction ... Leonore Tiefer, clinical professor of psychiatry at New York University, says a textbook case of disease mongering is the creation and promotion of "female sexual dysfunction". (Sydney Morning Herald -- World)
We don't have to buy into health hype Apr 19, 2006
"Scientists have accused major pharmaceutical firms of 'medicalising' problems like high cholesterol or the symptoms of the menopause in a bid to increase profits ... exaggerating conditions and turning them into something more serious. Female sexual dysfunction, attention deficit hyperactivity disorder (ADHD) and 'restless legs' syndrome have all been promoted by the pharmaceutical industry in the hope of selling more drugs, they say.". Now, this is an incredibly interesting set of ideas, but... (Guardian Unlimited -- Life)
Drug firms 'hype up diseases to boost sales' Apr 12, 2006
Female sexual dysfunction, attention deficit hyperactivity disorder (ADHD) and "restless legs" syndrome have all been promoted by the pharmaceutical industry in the hope of selling more drugs, they say. High cholesterol and osteoporosis-are being described as diseases in their own right, the researchers claim, turning healthy people into patients. (Daily Mail - UK)
Drugs companies 'inventing diseases to boost their profits' Apr 11, 2006
The special issue, edited by David Henry, of Newcastle University in Australia, and Ray Moynihan, an Australian journalist, reports that conditions such as female sexual dysfunction, attention deficit hyperactivity disorder (ADHD) and restless legs syndrome have been promoted by companies hoping to sell more of their drugs ... The prevalence of female sexual dysfunction, one paper claims, has been highly exaggerated to provide a new market for drugs, while the makers of anti-impotence medicines,... (Times Online)
Drug firms 'turning healthy people into patients' Apr 11, 2006
The latter, according to some of the world's biggest, most profitable pharmaceutical companies, which have come up with a range of new drugs to treat "restless legs syndrome", attention deficit hyperactivity disorder in children, and female sexual dysfunction ... According to Leonore Tiefer, clinical professor of psychiatry at New York University, a textbook case of disease mongering is the creation and promotion of "female sexual dysfunction" ... Female sexual dysfunction (FSD)Publicised as the... (Guardian Unlimited)
Blaming the Big Drug Makers Mar 26, 2006
The authors study diseases whose medical component and extent they say are exaggerated, including irritable bowel syndrome, female sexual dysfunction and attention deficit disorder. With regard to the last, in some U.S. states as many as 10% of white boys are given prescription drugs that are essentially legalized amphetamines. (Los Angeles Times)
50% women over thirty face risk of FSD Feb 19, 2006
A great many women suffer from what is called female sexual dysfunction (FSD). Doctors, however, say that most of them are unaware of the condition and therefore do not seek treatment for it. (India Times, India -- India)
Piribo: Sexual Disorders Drug Market to Increase 74% as Treatments for Women Outstrip Those for Male Dysfunction Jan 25, 2006
The report predicts that the female sexual dysfunction sector may outperform those therapies indicated for male sexual disorders within a decade. However, as a relatively young and controversial therapy area, new drugs for sexual disorders are subject to intense regulatory scrutiny and navigating through the drug approval process is challenging particularly for new sexual disorder indications, which is evident from recent market authorisation setbacks for Proctor & Gamble's Intrinsa for female... (CBS MarketWatch - Press Releases)
The fool's gold that heals Jan 14, 2006
Journalist Ray Moynihan located the original study detailed in the Journal of the American Medical Association which showed that 43% of women suffered from female sexual dysfunction (FSD); he found the authors had close links to Pfizer, which was testing Viagra in women at the time. He also found 1,500 women, aged between 18 and 59, had been asked if they had experienced any of seven problems for two months or more over the previous year. (Guardian Unlimited)
Top Ten: The week's top news and analysis, Jan. 2-6 Jan 7, 2006
On "MarketWatch Weekend," aired on CBS television stations, find out about the race to develop a drug to treat female sexual dysfunction, the New York boat show, Viacom's split and more. Our online weekend cover story, meanwhile, looks at how mining and metals stocks are likely to perform in 2006, given the continued strength in gold. (CBS MarketWatch - Stories)
